Biomea Fusion (BMEA) Earnings Date & Reports

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BMEA is expected to report earnings to rise 22.71% to -20 cents per share on August 03

Biomea Fusion BMEA Stock Earnings Reports

Q2'26

Est.

$-0.21

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.29

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.03

The last earnings report on May 11 showed earnings per share of -17 cents, beating the estimate of -23 cents. With 270.33K shares outstanding, the current market capitalization sits at 89.65M.

View a ticker or compare two or three

Compare

BMEA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BMEA